☆ 4.6 Article

GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study

CIRCULATION-HEART FAILURE (2014)

Get Full Text
Add to Collection

Journal

CIRCULATION-HEART FAILURE
Volume 7, Issue 4, Pages 673-679

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCHEARTFAILURE.114.000346

Keywords

clinical trial; glucagon-like peptide-1; heart failure; insulin resistance

Categories

Cardiac & Cardiovascular Systems

Funding

  1. National Heart, Lung, and Blood Institute (co-ordinating center) [U10 HL084904]
  2. National Heart, Lung, and Blood Institute (regional clinical centers) [U10 HL110312, U10 HL110337, U10 HL110342, U10 HL110262, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, U10 HL110338]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.